A

ADC Therapeutics SA
D

ADCT

1.99500
USD
0.03
(1.27%)
Market Open
Volume
14,972
EPS
-2
Div Yield
-
P/E
-1
Market Cap
193,379,234
OverviewSignalsIdeasNews
Related Instruments
    C
    CIEN
    0.290
    (0.33%)
    87.690 USD
    CSCO
    CSCO
    -0.110
    (-0.19%)
    58.390 USD
    DELL
    DELL
    2.560
    (2.21%)
    118.350 USD
    HPE
    HPE
    0.060
    (0.28%)
    21.670 USD
    HPQ
    HPQ
    -0.015
    (-0.05%)
    32.930 USD
    IBM
    IBM
    -1.250
    (-0.56%)
    222.020 USD
    I
    INFN
    -0.03000
    (-0.45%)
    6.57000 USD
    INTC
    INTC
    0.480
    (2.46%)
    19.980 USD
    J
    JNPR
    0.000
    (0.00%)
    37.220 USD
    NTAP
    NTAP
    -0.770
    (-0.65%)
    117.710 USD
    More
News

Title: ADC Therapeutics SA

Sector: Healthcare
Industry: Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.